Background: Gadoxetic acid is one of the hepatobiliary-specific agents and so can be used for contrast-enhanced magnetic resonance cholangiography (CE-MRC). The aim of our study was to compare the performance of CE-MRC with that of T2-weighted magnetic resonance cholangiography (T2W-MRC), and also to ascertain the effectiveness of both modalities combined for visualizing anatomic structures of the biliary tree in patients with liver cirrhosis. Methods: Fifty-six patients underwent CE-MRC and T2W-MRC imaging. In the CE-MRC studies, hepatobiliary phase images were acquired 20 minutes after contrast injection. Two radiologists first evaluated the T2W-MRC and CE-MRC images separately in random order, and then they reviewed both images together 8 weeks later. The readers graded the quality of visualization of each biliary duct and the entire biliary tree (overall rating) using a five-point scale. Images with a grade of 3 or 4 were considered to provide sufficient visualization for clinical application, and those with a grade of 2 or less were considered to provide insufficient visualization. Laboratory data, ChildePugh classification, and model for end-stage liver disease score were also recorded. Results: The overall rating of T2W-MRC was significantly higher than that of CE-MRC ( p < 0.001), although combined T2W/CE-MRC provided better visualization of biliary segments than T2W-MRC alone ( p ¼ 0.025). There were no significant differences between liver function and the overall rating of CE-MRC. Conclusion: CE-MRC is not superior to conventional T2W-MRC with respect to biliary visualization in patients with liver cirrhosis. However, a combination of T2W-MRC and CE-MRC provides significantly better visualization of biliary structures than T2W-MRC alone.
Introduction
T2-weighted magnetic resonance cholangiography (T2W-MRC) is a widely accepted noninvasive method for imaging choledocholithiasis, biliary tract obstruction and dilatation, and biliary anatomy. 1e5 However, the technique is associated with several interpretive pitfalls, which may result in Conflicts of interest: The authors declare that there are no conflicts of interest related to the subject matter or materials discussed in this article.diagnostic errors. 6e8 In addition, T2W-MRC yields static images in contrast to real-time images obtained using endoscopic retrograde cholangiopancreatography or percutaneous transhepatic cholangiography. Moreover, T2W-MRC cannot discriminate between different kinds of fluids (for example, bile leakage from small ascites), and soft tissue contrast can be lost with a very long echo time.
Several studies have shown that contrast-enhanced magnetic resonance cholangiography (CE-MRC) has the potential to provide a "one stop shop" for diagnosing anatomic and functional abnormalities of the biliary tree.
9e13 Gadoliniumethoxybenzyl-diethylenetriaminepentaacetic acid (gadoxetic acid) and gadobenate dimeglumine can be used as intravasculareinterstitial contrast agents for dynamic magnetic resonance imaging (MRI) and as hepatocyte-specific contrast agents for MRC. However, because of earlier onset and longer duration, gadoxetic acid may provide better visualization of biliary structures within a shorter period of time than gadobenate dimeglumine. 14 Recent studies have shown that CE-MRC with gadoxetic acid is an effective technique for evaluating biliary tract anatomy, obstruction, and active bile leakage in patients with normal liver function.
15e18 Few studies, however, have investigated the quality of bile duct visualization using CE-MRC in patients with liver cirrhosis, 19 and to the best of our knowledge, no studies have compared the quality of visualization obtained by CE-MRC with that obtained by T2W-MRC in patients with cirrhosis. The purpose of our study was to compare the performance of CE-MRC with that of T2W-MRC, and assess the effectiveness of both modalities combined for visualizing anatomic structures of the biliary tree in patients with liver cirrhosis.
Methods

Patients
This retrospective study was approved by the Institutional Review Board of our hospital. A total of 60 consecutive patients underwent gadoxetic acid-enhanced MRI of liver for suspected focal liver lesions during a 16-month period (from October 2008 to January 2011). The focal lesions were diagnosed either histologically or radiologically, and comprised hepatocellular carcinoma in 51 patients, hepatocholangiocarcinoma in two patients, dysplastic nodules in two patients, hemangioma in one patient, and focal nodular hyperplasia in one patient. No abnormal pathology was detected in three patients. The inclusion criteria for our study were as follows: (1) patients must have liver cirrhosis; (2) laboratory and MRI studies should have been conducted within a 2-week period; and (3) both gadoxetic acid-enhanced MRC and T2W-MRC images should be available for review. A total of 56 patients fulfilled the criteria and were enrolled into the study. The cohort comprised 43 men and 13 women in the age range of 30e82 years (mean age, 59.9 years). The diagnosis of cirrhosis was established histologically in 43 patients (biopsy, n ¼ 14; surgical resection, n ¼ 21; liver transplantation, n ¼ 8) and was based on the combination of clinical, laboratory, endoscopic, and ultrasound findings in 13 patients. The clinical diagnosis of liver cirrhosis was made in patients with chronic liver disease who had one or more of the following clinical findings: firm liver and ascites, signs of collateral circulation, prothrombin index <85%, ultrasonographic evidence of irregular liver surface and heterogeneity, and endoscopic evidence of esophageal varices. 20 No biliary duct dilatations were observed in any of the 56 patients.
The underlying causes of liver cirrhosis were hepatitis B (n ¼ 28), hepatitis C (n ¼ 16), hepatitis B and hepatitis C combined (n ¼ 4), alcoholic chronic hepatitis (n ¼ 4), and cryptogenic cirrhosis (n ¼ 4). Hepatic function was classified as ChildePugh Class A in 31 patients, ChildePugh Class B in 13 patients, and ChildePugh Class C in 12 patients.
MRI technique
All MR studies were performed with a 1.5-T MR scanner (Gyroscan ACS-NT Intera; Philips, Best, The Netherlands) and a phased-array body coil. Navigator-triggered threedimensional (3D) T2W-MRC images were obtained during free breathing (1800/650; refocusing flip angle, 90
; field of view (FOV), 300 mm; matrix, 512 Â 512; echo train length, 115; slab thickness, 80 mm; section thickness, 1 mm; interpolation to 80 sections of 1-mm intervals; parallel acquisition technique factor, 2; no phase wrap option; acquisition time, 260e300 seconds). A whole-volume maximum-intensity projection reformation was applied in the coronal plain.
For contrast-enhanced MRI with gadoxetic acid, all patients received a 0.025 mmol/kg (0.1 mL/kg) dose of gadoxetic acid (Primovist; Bayer Schering Pharma, Berlin, Germany). The contrast agent was administered as a manual bolus injection at a speed of approximately 2 mL/second through peripheral veins. The line was flushed with 20 mL of 0.9% saline. Dynamic 3D T1W fast-field echo imaging (repetition time (TR)/echo time (TE), 10.2e10.7 milliseconds/5 milliseconds; slice thickness, 3 mm; matrix, 192 Â 256; number of excitations (NEX), 1; flip angle, 15 ; FOV, 38e40 cm) was carried out before and 25e30 seconds (arterial phase), 55e60 seconds (portal phase), and 85e90 seconds (venous phase) after the injection of the contrast agent. Delayed MRI at 20 minutes after the application of gadoxetic acid was performed with the same parameters as used for the dynamic study. CE-MRC images were reconstructed using a coronal oblique multiplanar reformatted image generated from the 20-minute delayed 3D T1W images.
Imaging evaluation
Imaging analysis was performed on a dual-screen diagnostic workstation (GE Healthcare, Milwaukee, WI, USA). Images were evaluated by two experienced radiologists (with 15 and 7 years of clinical experience in abdominal MR) who were not aware of the patients' clinical characteristics or laboratory results. Readers categorized the MRC images into three groups: T2W-MRC, CE-MRC, and a combined group (T2W-MRC plus CE-MRC). Image review was based on source images, multiplanar reformats, and maximum intensity projections. To reduce reviewer bias, T2W-MRC and CE-MRC images were arranged in random order and evaluated separately. Approximately 8 weeks later, the radiologists reviewed the combined T2W-MRC and CE-MRC images.
The two readers were asked to evaluate all MR image sets and record the bile duct visualization grading scores. The following structures were evaluated: the common bile duct (CBD), the common hepatic duct (CHD), and the right and left hepatic ducts and their secondary branches. The quality of visualization of the bile ducts was assessed using a five-point Likert-type scale as follows: Grade 0, nonvisualization of the ducts; Grade 1, partial visualization of less than half of the duct, high to moderate artifacts, or extensive superimposition of other anatomic structures; Grade 2, visualization of more than half of the duct, few to moderate artifacts, or moderate superimposition of other anatomic structures; Grade 3, total visualization of its entire length with ambiguous margins, few artifacts, or minimal superimposition of other anatomic structures; and Grade 4, excellent visualization with clear margins. 9 Disagreements in imaging evaluation between the two radiologists were resolved by consensus with a third radiologist. The images of the bile ducts ranked as 3 or 4 were grouped as "sufficient visualization" for clinical application, and those ranked as 2 or less were grouped as "insufficient visualization" (Fig. 1) .
In addition to grading the quality of visualization of each biliary duct, the readers also graded the visualization of the entire biliary tree (overall rating). When all the segments, including CBD, CHD, and right and left hepatic ducts, could be visualized, the overall rating was deemed to be "sufficient." If any one of the segments could not be visualized, the overall rating was deemed insufficient. 19 Patients' charts were reviewed and the following serum parameters were recorded: serum total bilirubin, platelet count, creatinine, prothrombin time, glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, and albumin. ChildePugh classification, ChildePugh score, and model for end-stage liver disease (MELD) score were also determined for each patient. A patient's MELD score is calculated using values for serum creatinine, total bilirubin, and the international normalized ratio as follows: MELD ¼ 9.57 Â Log e (creatinine) þ 3.78 Â Log e (total bilirubin) þ 11.2 Â Log e (international normalized ratio) þ 6.43. 21 
Statistical analysis
We used a weighted kappa statistic to measure interviewer agreement according to each biliary segment. Serial weighted pairwise comparisons across two reviewers were performed, and an average kappa value was calculated. A kappa value of 0.00 indicated no agreement; 0.01e0.20, slight agreement; 0.21e0.40, fair agreement; 0.41e0.60, moderate agreement; 0.61e0.80, good agreement; and 0.81e1.00, excellent agreement. Using T2W-MRC as a standard reference, the overall ratings and ratings for visualization of biliary segments were compared between CE-MRC and T2W-MRC and between the combined group and T2W-MRC using the Wilcoxon signedrank test. Analysis of the relationships between the overall rating of CE-MRC and various liver function parameters was also performed using the Wilcoxon signed-rank test. A p value of <0.05 was considered to indicate statistical significance. All statistical analyses were performed using the statistical package SPSS for Windows (version 20.0.0; SPSS, Chicago, IL, USA).
Results
A total of 328 biliary segments in 56 patients were evaluated. Eight segments were missing in four patients because they had undergone right (n ¼ 3) or left (n ¼ 1) hemihepatectomy. The bile ducts were not visible on T2W-MRC images in three patients (5.4%) or on CE-MRC images in two patients (3.6%). The inter-reviewer agreement for the degree of segmental visualization reached good to excellent levels (k ¼ 0.76e0.94) ( Table 1 ). In two of the three patients for whom the bile ducts were not visible on T2W-MRC images, there was sufficient visualization for anatomical diagnosis on CE-MRC images (Fig. 2) . The ratings for visualization of each biliary segment and the overall ratings in the T2W-MRC group, CE-MRC group, and combined group are shown in Table 2 . For segment-based visualization of each bile duct, the combined group showed significantly better visualization of the CBD, CHD, and bilateral hepatic ducts than T2W-MRC alone. However, no significant differences in visualization of the secondary branches were found. In addition, there were no significant differences between CE-MRC and T2W-MRC in visualization of any of the biliary segments, with the exception of the left hepatic duct ( p ¼ 0.004).
Based on the overall rating, CE-MRC alone provided sufficient visualization of the biliary tree in only 35.7% (20/56) of patients, whereas T2W-MRC alone provided sufficient visualization in 66.1% (37/56) of patients. However, T2W-MRC/ CE-MRC allowed for sufficient visualization in 71.4% (40/ 56) of patients. The overall rating of combined imaging was significantly better than that of T2W-MRC imaging alone ( p ¼ 0.025), and the overall rating of T2W-MRC alone was significantly better than that of CE-MRC alone ( p < 0.001).
We then analyzed whether liver function affected the quality of visualization of the biliary tract on CE-MRC images. We found that although the number of images with insufficient visualization tended to be higher in patients with ChildePugh classification C, higher ChildePugh scores, higher MELD scores, and higher total bilirubin levels, there were no significant differences between liver function parameters and visualization quality (Table 3) . Overall rating taking into account the total performance of CBD, CHD, RHD, and LHD. CBD ¼ common bile duct; CE-MRC ¼ gadoxetic acid-enhanced magnetic resonance cholangiography; CHD ¼ common hepatic duct; LHD ¼ left hepatic duct; RHD ¼ right hepatic duct; T2W-MRC ¼ T2-weighted magnetic resonance cholangiography.
Discussion
The differences in the performance of T2W-MRC and CE-MRC may be due to the different imaging techniques. T2W-MRC benefits from a sufficiently long TE and displays only the fluid in the bile ducts with high signal intensity. When gadoxetic acid is used as a hepatobiliary contrast agent for functional imaging, it enhanced the biliary lumen via excretion into the bile ducts by a cellular process after its uptake by the hepatocyte.
Our results showed that the combination of T2W-MRC and CE-MRC provides better visualization of the biliary tree than T2W-MRC alone, especially for visualizing the CBD, CHD, and bilateral hepatic bile ducts. Gupta et al 22 reported that a combination of T2W images and gadolinium-enhanced T1W images during the hepatocyte phase is generally required for optimal evaluation of the biliary system in patients with normal liver function. CE-MRC can also increase the radiologist's confidence, especially in the evaluation of choledocholithiasis or identification of anatomic biliary ductal variants for living donors. 13, 16, 17 We found that the combination of CE-MRC and T2W-MRC did not significantly improve visualization of small intrahepatic bile ducts of the bilateral second branches relative to T2W-MRC alone ( p ¼ 0.157). In an attempt to improve visualization of the small intrahepatic bile ducts, Mangold et al 16 reported that second-and third-order bile ducts are more accurate in CE-MRC when delayed images are obtained 1.5 hours after the application of gadoxetic acid. In our study, the delay was only for 20 minutes, which might be the reason why the small intrahepatic bile ducts were poorly depicted in our study.
The overall rating of T2W-MRC was higher than that of CE-MRC alone in patients with liver cirrhosis for two reasons. It is well understood that decreased and delayed liver parenchymal enhancement is related to liver dysfunction, leading to decreased excretion of gadoxetic acid into the biliary tract. In our study, only 35.7% of patients with liver cirrhosis had CE-MRC images with sufficient visualization of the biliary tree. Tschirch et al 19 also reported that in only about 40% of patients in the cirrhosis group the overall CE-MRC image quality was rated as sufficient for anatomical diagnosis within 30 minutes of contrast application. The second reason why the overall rating of CE-MRC was inferior to that of T2W-MRC is that enhancement of liver parenchyma decreases the contrastnoise ratio of the biliary tree. In an in vivo Phase I clinical evaluation performed in healthy volunteers receiving different doses of gadoxetic acid, Bollow et al 23 reported that low doses (10 mmol/kg) of gadoxetic acid were helpful for assessing the intrahepatic bile ducts. Further clinical studies are needed to determine whether low doses of gadoxetic acid improve the quality of CE-MRC images in patients with liver cirrhosis.
In our study, T2W-MRC images did not show the biliary tree in three patients. Studies have shown that signal loss in the bile ducts could be due to air bubbles, hemorrhage, or debris. 24e26 The possibility of signal loss due to air bubbles or hemorrhage in our study was excluded on abdominal ultrasound and conventional T1W, T2W, and dynamic MRI. Thick bile inside the biliary tree is the most likely reason for lack of visualization. Interestingly, there was sufficient visualization on CE-MRC images in two of the three patients. We suggest that the hepatobiliary phase of T1W MRI with gadoxetic acid might be a complementary method in clinical practice, especially when T2W-MRC images are inconclusive.
In this study, we evaluated the relationship between various laboratory data representing liver function and the overall rating of CE-MRC. We found that although the number of images with insufficient visualization tended to be higher in patients with ChildePugh classification C, higher ChildePugh scores, higher MELD scores, and higher total bilirubin levels, there were no significant differences between liver function parameters and visualization quality. One reason for this may be that there were few patients with ChildePugh classification C in our study. In addition, few studies have evaluated the relation between various laboratory parameters of liver function and the uptake and excretion of gadoxetic acid in patients with liver cirrhosis. 19,27e29 Their results showed disagreements about the relationships between laboratory parameters and the uptake or excretion of gadoxetic acid. Even Motosugi et al 27 reported that no biological markers of liver function are significantly correlated with liver enhancement.
We acknowledge that our study had the following limitations. First, hepatocyte phase imaging was performed 20 minutes after the injection of contrast agent. A longer delay may be needed for patients with liver cirrhosis. The optimal timing for biliary imaging in patients with impaired liver function should be studied in the future. Second, liver cirrhosis was not histologically confirmed in all the patients.
In conclusion, CE-MRC is not superior to conventional T2W-MRC in biliary visualization in patients with liver cirrhosis. However, a combination of T2W-MRC and CE-MRC provides significantly better visualization of biliary structures than T2W-MRC alone. The hepatobiliary phase of ChildePugh score, MELD score, total bilirubin, and albumin value were expressed as mean ± standard deviation. Low platelet count indicates a count of <150 Â 10 3 /mL; prolonged PT indicates a PT value of >12 seconds; abnormal GOT or GPT indicates a level of >40 U/L. GOT ¼ glutamic oxaloacetic transaminase; GPT ¼ glutamic pyruvic transaminase; MELD ¼ model for end-stage liver disease; MRC ¼ magnetic resonance cholangiography; PT ¼ prothrombin time.
T1W MRI with gadoxetic acid might be a complementary method in clinical practice, especially when T2W-MRC images are inconclusive.
